Shan Lin, MD, tells us about the unique dual mechanism of action of VYZULTA^®

Glaucoma specialists discuss the efficacy of VYZULTA^®, as proven in clinical trials

Quang Nguyen, MD, Gagan Sawhney, MD, and Janet Serle, MD, talk about safety and tolerability of VYZULTA^®

Shan Lin, MD, Quang Nguyen, MD, Gagan Sawhney, MD, and Janet Serle, MD, share their experiences with VYZULTA^® so far

Practical, enduring, uplifting – why 2021 needs to be about feeding the human spirit

What do the Glaucoma Research Foundation survey results tell us about patients’ pandemic experiences?

The goal of VISION 2020 was to reduce avoidable sight loss, but there is still work to be done to redress gender disparities

A failure to meet preventable blindness targets speaks to the need for change

Everything you need to know about responding to patient-initiated verbal harassment

A speedy way of measuring patients’ eye pressure when all visits are canceled